Lyme disease

Progress in Lyme Disease Vaccine Development

by
Vaccine_development

Valneva reports the subjects in Phase II clinical trial of Lyme disease vaccine develop antibodies.  The results were positive enough to inspire Pfizer to join with Valneva to continue testing in the next phase of clinical trials and, hopefully, bring this to market. Find out more about the vaccine strategy and Lyme disease: Read More … Read more

New Hope for Lyme Disease Prevention

by
Blacklegged_tick

Lyme disease is caused by bacteria (Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii) that are delivered by a bite from an infected tick (Figure 1). The Centers for Disease Control (1) recommend a preventative (prophylactic) single dose of the antibiotic doxycycline for adults bitten by a mosquito with a high probability of carrying the Lyme-causing … Read more